Mauritius vs North Macedonia: The number of people with susceptibility test result for rifampicin
Mauritius
83
in 2021
North Macedonia
100
in 2021
Mauritius rank
112th
North Macedonia rank
109th
The number of people with susceptibility test result for rifampicin over time
- Mauritius
- North Macedonia
How they compare
North Macedonia currently reports 100 against 83 in Mauritius, a difference of 17.
That makes North Macedonia's figure about 1.2 times Mauritius's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was North Macedonia ahead.
Mauritius ranks 112th and North Macedonia ranks 109th of 155 countries.
North Macedonia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Mauritius | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 111 | 130 | 19 | North Macedonia |
| 2020s | 83 | 90.5 | 7.5 | North Macedonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Mauritius or North Macedonia?
- North Macedonia, at 100 against 83 in Mauritius as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Mauritius and North Macedonia?
- 17, with North Macedonia ahead.
- How many years of comparable data are there for Mauritius and North Macedonia?
- 5 years are reported by both, from 2017 to 2021.
- How do Mauritius and North Macedonia rank globally for the number of people with susceptibility test result for rifampicin?
- Mauritius ranks 112th and North Macedonia ranks 109th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.